lingo.lol is one of the many independent Mastodon servers you can use to participate in the fediverse.
A place for linguists, philologists, and other lovers of languages.

Server stats:

66
active users

#MultipleSclerosis

2 posts2 participants0 posts today
Gregory MS<p>We have a big update! A new search page, improvements to articles, and a ranking of top authors publishing <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> research. <a href="https://gregory-ms.com/post/2025-07-05-clearer-view-into-multiple-sclerosis-research/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">gregory-ms.com/post/2025-07-05</span><span class="invisible">-clearer-view-into-multiple-sclerosis-research/</span></a> <a href="https://med-mastodon.com/tags/mschat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>mschat</span></a> <a href="https://med-mastodon.com/tags/ai" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ai</span></a></p>
Spooky Panda 🇺🇦<p>It's that time again, but least I have my Dunks. That's the important part. 🍹</p><p><a href="https://mindly.social/tags/Autoimmune" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Autoimmune</span></a> <a href="https://mindly.social/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> <a href="https://mindly.social/tags/InfusionTherapy" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>InfusionTherapy</span></a></p>
Will Berard 🫳🎤🫶<p><a href="https://mastodon.acm.org/tags/Introduction" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Introduction</span></a> Hashtags, so I can pin this post and take them out of my profile:</p><p><a href="https://mastodon.acm.org/tags/Education" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Education</span></a> <a href="https://mastodon.acm.org/tags/Research" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Research</span></a> <a href="https://mastodon.acm.org/tags/Phd" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Phd</span></a>, <a href="https://mastodon.acm.org/tags/BCS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>BCS</span></a> <a href="https://mastodon.acm.org/tags/Computing" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Computing</span></a> <a href="https://mastodon.acm.org/tags/Teacher" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Teacher</span></a> <a href="https://mastodon.acm.org/tags/CCT" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>CCT</span></a><br><a href="https://mastodon.acm.org/tags/CSEd" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>CSEd</span></a> <a href="https://mastodon.acm.org/tags/Programming" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Programming</span></a> <a href="https://mastodon.acm.org/tags/BCS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>BCS</span></a><br><a href="https://mastodon.acm.org/tags/ActuallyAutistic" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ActuallyAutistic</span></a><br><a href="https://mastodon.acm.org/tags/ActuallyADHD" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ActuallyADHD</span></a><br>I live with <a href="https://mastodon.acm.org/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> <br><a href="https://mastodon.acm.org/tags/Zen" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Zen</span></a> / <a href="https://mastodon.acm.org/tags/Nonduality" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Nonduality</span></a> <a href="https://mastodon.acm.org/tags/Buddhist" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Buddhist</span></a>, weirdly into <a href="https://mastodon.acm.org/tags/Jung" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Jung</span></a><br><a href="https://mastodon.acm.org/tags/Research" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Research</span></a> topics:<br>- <a href="https://mastodon.acm.org/tags/EdAI" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>EdAI</span></a> / <a href="https://mastodon.acm.org/tags/AIEd" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>AIEd</span></a> - <a href="https://mastodon.acm.org/tags/LLMs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>LLMs</span></a> in <a href="https://mastodon.acm.org/tags/Education" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Education</span></a><br>- <a href="https://mastodon.acm.org/tags/CriticalStudies" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>CriticalStudies</span></a> of <a href="https://mastodon.acm.org/tags/EdTech" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>EdTech</span></a><br>- <a href="https://mastodon.acm.org/tags/Neurodiversity" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Neurodiversity</span></a> in <a href="https://mastodon.acm.org/tags/Education" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Education</span></a>, and the experience of ND educators.</p>
Anna-Maria 🐦‍⬛<p>2025. Chorzy na stwardnienie rozsiane, zdiagnozowani po 2010 praktycznie nie lądują na wózkach. Leków jest kilkanaście, wdrożone odpowiednio wcześnie powodują, że choroba staje się przewlekle akceptowalna. Trzeba pamiętać o lekach, czasami robić sobie zastrzyki, regularnie meldować się na kontrole i odbiory leków, ale żyje się NORMALNIE. Praca, sport, dzieci. Jeśli nie powiem komuś że mam SM (tu mem z pękającym pryszczersem), to nikt nie będzie wiedział. Bba, jestem w tak głębokiej remisji, że jeśli pójdę w dobrej formie do obcego neurologa, to w badaniu fizykalnym może nie wybadać, wsypie mnie tylko MRI.<br>I nie jest jakimś szczególnym odkryciem, że wszystko to dzięki wdrożonemu wcześnie, agresywnemu, systematycznemu leczeniu.</p><p>Dlaczego więc ciągle na grupach dla chorych czytam "Czy są tutaj osoby, które świadomie NIE zdecydowały się na leczenie?" i odpowiedzi w stylu "tylko natura, spróbuj ziół, homeopatia działa".</p><p>To te same osoby, które za 10 lat będą u tych samych znachorów szukały metod na wstanie z (refundowanego) wózka inwalidzkiego i narzekały, że im lekarze nie pomogli. <br>To jak w tym szmoncesie o rabinie, loterii i Bogu. Pomogliby, gdybyście, debile, dali im szansę!</p><p><a href="https://pol.social/tags/sm" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>sm</span></a> <a href="https://pol.social/tags/stwardnienierozsiane" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>stwardnienierozsiane</span></a> <a href="https://pol.social/tags/multiplesclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>multiplesclerosis</span></a></p>
Bruno Amaral<p>Our feed for <a href="https://mastodon.social/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> trials just got better <a href="https://gregory-ms.com/trials/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">gregory-ms.com/trials/</span><span class="invisible"></span></a> It's updated in real time. <a href="https://mastodon.social/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MSchat</span></a> <span class="h-card" translate="no"><a href="https://med-mastodon.com/@gregoryMS" class="u-url mention" rel="nofollow noopener" target="_blank">@<span>gregoryMS</span></a></span> <a href="https://mastodon.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ClinicalTrials</span></a></p>
Dave W<p>Interesting thing I’ve found: people take you seriously when you call it multiple sclerosis, but handwave you when you call it MS.</p><p>Maybe not knowing the acronym and not wanting to appear not to know? We all know how society incentivises bluffing, over just asking the question like a grownup.</p><p><a href="https://basilisk.gallery/tags/ms" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ms</span></a> <a href="https://basilisk.gallery/tags/multiplesclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>multiplesclerosis</span></a></p>
Gregory MS<p>We have exciting news for medical research! We have added tracking of pre-prints from bioRxiv &amp; medRxiv, with added filters to focus more on your research. <br>We gather the research so you have more time to focus on your insights.</p><p><a href="https://gregory-ms.com/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">gregory-ms.com/</span><span class="invisible"></span></a> <a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MSchat</span></a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a></p>
Tom Kindlon<p>Mind in the mist: the interplay between fatigue, information processing and brain fog </p><p><a href="https://www.tandfonline.com/doi/full/10.1080/21641846.2025.2513194" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">tandfonline.com/doi/full/10.10</span><span class="invisible">80/21641846.2025.2513194</span></a></p><p>Image is from the latest Science for ME weekly update</p><p><span class="h-card" translate="no"><a href="https://a.gup.pe/u/mecfs" class="u-url mention" rel="nofollow noopener" target="_blank">@<span>mecfs</span></a></span><br><a href="https://disabled.social/tags/MyalgicEncephalomyelitis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MyalgicEncephalomyelitis</span></a> <a href="https://disabled.social/tags/ChronicFatigueSyndrome" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ChronicFatigueSyndrome</span></a> <a href="https://disabled.social/tags/MEcfs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MEcfs</span></a> <a href="https://disabled.social/tags/CFS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>CFS</span></a> <a href="https://disabled.social/tags/PwME" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PwME</span></a> <span class="h-card" translate="no"><a href="https://a.gup.pe/u/longcovid" class="u-url mention" rel="nofollow noopener" target="_blank">@<span>longcovid</span></a></span><br><a href="https://disabled.social/tags/LongCovid" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>LongCovid</span></a> <a href="https://disabled.social/tags/PASC" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PASC</span></a> <a href="https://disabled.social/tags/PwLC" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PwLC</span></a> <a href="https://disabled.social/tags/postcovid" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>postcovid</span></a> <a href="https://disabled.social/tags/postcovid19" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>postcovid19</span></a> <a href="https://disabled.social/tags/LC" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>LC</span></a> <a href="https://disabled.social/tags/Covidlonghaulers" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Covidlonghaulers</span></a> <a href="https://disabled.social/tags/PostCovidSyndrome" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PostCovidSyndrome</span></a> <a href="https://disabled.social/tags/longhaulers" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>longhaulers</span></a> <a href="https://disabled.social/tags/COVIDBrain" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>COVIDBrain</span></a> <a href="https://disabled.social/tags/NeuroPASC" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NeuroPASC</span></a><br> <a href="https://disabled.social/tags/brainfog" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>brainfog</span></a> <a href="https://disabled.social/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> <span class="h-card" translate="no"><a href="https://a.gup.pe/u/multiplesclerosis" class="u-url mention" rel="nofollow noopener" target="_blank">@<span>multiplesclerosis</span></a></span></p>
Tom Kindlon<p>“Rest recharges my energy”; experiences and perceptions of rest in adults with long-term conditions and fatigue in rehabilitation: a qualitative study<br><a href="https://www.tandfonline.com/doi/full/10.1080/09638288.2025.2512587" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">tandfonline.com/doi/full/10.10</span><span class="invisible">80/09638288.2025.2512587</span></a></p><p>"Lived-experience participants noted physical symptoms, while HCPs highlighted “all-or-nothing” thinking as a significant barrier."</p><p><a href="https://disabled.social/tags/longcovid" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>longcovid</span></a> <span class="h-card" translate="no"><a href="https://a.gup.pe/u/longcovid" class="u-url mention" rel="nofollow noopener" target="_blank">@<span>longcovid</span></a></span> <a href="https://disabled.social/tags/fatigue" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>fatigue</span></a> <a href="https://disabled.social/tags/chronicfatigue" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>chronicfatigue</span></a> <a href="https://disabled.social/tags/fibromyalgia" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>fibromyalgia</span></a> <span class="h-card" translate="no"><a href="https://a.gup.pe/u/fibromyalgia" class="u-url mention" rel="nofollow noopener" target="_blank">@<span>fibromyalgia</span></a></span> <a href="https://disabled.social/tags/multiplesclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>multiplesclerosis</span></a> <span class="h-card" translate="no"><a href="https://a.gup.pe/u/multiplesclerosis" class="u-url mention" rel="nofollow noopener" target="_blank">@<span>multiplesclerosis</span></a></span> <a href="https://disabled.social/tags/arthritis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>arthritis</span></a> <a href="https://disabled.social/tags/Sjogren" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Sjogren</span></a> <a href="https://disabled.social/tags/Sj%C3%B6grens" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Sjögrens</span></a></p>
Gregory MS<p>Activation of Kir4.1 Channels by 2‐D08 Promotes Myelin Repair in Multiple Sclerosis</p><p><a href="https://gregory-ms.com/articles/296197/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">gregory-ms.com/articles/296197</span><span class="invisible">/</span></a></p><p><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MSchat</span></a> <a href="https://med-mastodon.com/tags/MS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MS</span></a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Neurology</span></a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a></p>
Gregory MS<p>A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy (X-TOLE4)</p><p><a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&amp;EUCT=2022-502282-24-00" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">euclinicaltrials.eu/search-for</span><span class="invisible">-clinical-trials/?lang=en&amp;EUCT=2022-502282-24-00</span></a></p><p><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MSchat</span></a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Neurology</span></a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ClinicalTrial</span></a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>botsFightMS</span></a></p>
Gregory MS<p>An Exploratory, Multicenter, Randomized, double-blind, placebo-controlled study evaluating the effect and safety of pitolisant in children and adolescents with Autism Spectrum Disorders.</p><p><a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&amp;EUCT=2023-503678-18-00" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">euclinicaltrials.eu/search-for</span><span class="invisible">-clinical-trials/?lang=en&amp;EUCT=2023-503678-18-00</span></a></p><p><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MSchat</span></a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Neurology</span></a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ClinicalTrial</span></a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>botsFightMS</span></a></p>
Gregory MS<p>A Phase 2 Safety, Tolerability, and Proof-of-Concept Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia (ALSP)</p><p><a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&amp;EUCT=2022-502505-15-00" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">euclinicaltrials.eu/search-for</span><span class="invisible">-clinical-trials/?lang=en&amp;EUCT=2022-502505-15-00</span></a></p><p><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MSchat</span></a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Neurology</span></a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ClinicalTrial</span></a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>botsFightMS</span></a></p>
Gregory MS<p>A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures (X-ACKT)</p><p><a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&amp;EUCT=2022-502286-16-00" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">euclinicaltrials.eu/search-for</span><span class="invisible">-clinical-trials/?lang=en&amp;EUCT=2022-502286-16-00</span></a></p><p><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MSchat</span></a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Neurology</span></a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ClinicalTrial</span></a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>botsFightMS</span></a></p>
Gregory MS<p>A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinson’s Disease With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene</p><p><a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&amp;EUCT=2022-501783-18-00" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">euclinicaltrials.eu/search-for</span><span class="invisible">-clinical-trials/?lang=en&amp;EUCT=2022-501783-18-00</span></a></p><p><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MSchat</span></a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Neurology</span></a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ClinicalTrial</span></a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>botsFightMS</span></a></p>
Gregory MS<p>A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures</p><p><a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&amp;EUCT=2022-502000-73-00" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">euclinicaltrials.eu/search-for</span><span class="invisible">-clinical-trials/?lang=en&amp;EUCT=2022-502000-73-00</span></a></p><p><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MSchat</span></a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Neurology</span></a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ClinicalTrial</span></a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>botsFightMS</span></a></p>
Gregory MS<p>A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple Sclerosis</p><p><a href="https://clinicaltrials.gov/study/NCT07008378?cond=Multiple+Sclerosis" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">clinicaltrials.gov/study/NCT07</span><span class="invisible">008378?cond=Multiple+Sclerosis</span></a></p><p><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MSchat</span></a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Neurology</span></a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ClinicalTrial</span></a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>botsFightMS</span></a></p>
Gregory MS<p>Effect of Bobath Therapy on Balance Alterations in Patients With Multiple Sclerosis</p><p><a href="https://clinicaltrials.gov/study/NCT07006259?cond=Multiple+Sclerosis" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">clinicaltrials.gov/study/NCT07</span><span class="invisible">006259?cond=Multiple+Sclerosis</span></a></p><p><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MSchat</span></a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Neurology</span></a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ClinicalTrial</span></a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>botsFightMS</span></a></p>
Gregory MS<p>RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis</p><p><a href="https://clinicaltrials.gov/study/NCT07006805?cond=Multiple+Sclerosis" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">clinicaltrials.gov/study/NCT07</span><span class="invisible">006805?cond=Multiple+Sclerosis</span></a></p><p><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MSchat</span></a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Neurology</span></a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ClinicalTrial</span></a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>botsFightMS</span></a></p>
Gregory MS<p>Prolonged nicotine exposure, via electronic cigarette, selectively increases Bdnf&amp;<a href="https://med-mastodon.com/tags/x2F" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>x2F</span></a>;TrkB transcription, dynorphin peptide levels and OLIG2 in male rat VTA</p><p><a href="https://gregory-ms.com/articles/296026/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">gregory-ms.com/articles/296026</span><span class="invisible">/</span></a></p><p><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MSchat</span></a> <a href="https://med-mastodon.com/tags/MS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MS</span></a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Neurology</span></a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a></p>